Life expectancy following surgery for pituitary tumours

OBJECTIVE Hypopituitarism, predominantly although not exclusively due to no nfunctioning pituitary tumours, has been associated with reduced life expec tancy. Mortality from vascular diseases contributed significantly to the ov erall increase in mortality in some, but not all of the studies published t o date. The aim of this study was to contribute further data to the debate regarding the putative association of vascular mortality with hypopituitari sm. DESIGN AND PATIENTS A retrospective case note review of patients undergoing pituitary surgery in Birmingham, between 1/1/70 and 1/1/92. Subjects were identified from neurosurgical and neuropathology records. 348 patients were identified of which 197 were male (median age at surgery 48.4, range 11-79 years) and 151 female (median age at surgery 47.8, range 9-78 years), All cause mortality and mortality from vascular disease was compared to the gen eral population of the UK using the Person Years computer programme. RESULTS There was a small increase in all cause mortality (SMR 1.2; 95% CI 0.95-1.55), but this was not statistically significant in this study (P = 0 .06). Mortality from vascular disease was reduced (SMR 0.7; 95% Cr 0.5-1.1; P = 0.03) particularly in the female cohort (SMR 0.5; 95% CI 0.2-1.0; P < 0.01) with the male subjects having similar mortality to that expected in a n age and sex matched control population (SMR 0.9; 95% CI 0.5-1.4; P = 0.26 ). CONCLUSION Although patients with pituitary deficiency may be subject to a small increase in all cause mortality, the results of this study do not sup port the view that hypopituitarism is associated with a significant increas e in vascular disease. There is a pressing need for a large prospective stu dy with comprehensive data collection, including both endocrine data and in formation regarding clinical outcome, to clarify this issue. In the interim it would seem prudent to base the need for GH replacement therapy on quali ty of life issues rather than any potential for increased longevity.